237 related articles for article (PubMed ID: 34099367)
41. The Epidemiology of Psoriatic Arthritis.
Ogdie A; Weiss P
Rheum Dis Clin North Am; 2015 Nov; 41(4):545-68. PubMed ID: 26476218
[TBL] [Abstract][Full Text] [Related]
42. Outcome measures in psoriatic arthritis.
Gladman DD; Mease PJ; Krueger G; van der Heidje DM; Antoni C; Helliwell PS; Kavanaugh AF; Nash P; Ritchlin CT; Strand CV; Taylor W
J Rheumatol; 2005 Nov; 32(11):2262-9. PubMed ID: 16265714
[TBL] [Abstract][Full Text] [Related]
43. Psoriatic arthritis.
Ocampo D V; Gladman D
F1000Res; 2019; 8():. PubMed ID: 31583079
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.
Ogdie A; Schwartzman S; Eder L; Maharaj AB; Zisman D; Raychaudhuri SP; Reddy SM; Husni E
J Rheumatol; 2014 Nov; 41(11):2315-22. PubMed ID: 25362717
[TBL] [Abstract][Full Text] [Related]
45. Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Karki C; Palmer JB; Etzel CJ; Kavanaugh A; Ritchlin CT; Malley W; Herrera V; Tran M; Greenberg JD
Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1692-1699. PubMed ID: 28376239
[TBL] [Abstract][Full Text] [Related]
46. The pathogenesis of psoriatic arthritis.
Veale DJ; Fearon U
Lancet; 2018 Jun; 391(10136):2273-2284. PubMed ID: 29893226
[TBL] [Abstract][Full Text] [Related]
47. Novel Treatment Concepts in Psoriatic Arthritis.
Boyd T; Kavanaugh A
Rheum Dis Clin North Am; 2015 Nov; 41(4):739-54. PubMed ID: 26476230
[TBL] [Abstract][Full Text] [Related]
48. Challenges in the clinical diagnosis of psoriatic arthritis.
Rida MA; Chandran V
Clin Immunol; 2020 May; 214():108390. PubMed ID: 32200113
[TBL] [Abstract][Full Text] [Related]
49. Consensus on the management of patients with psoriatic arthritis in a dermatology setting.
Gisondi P; Altomare G; Ayala F; Conti A; Dapavo P; De Simone C; Foti C; Idolazzi L; Lubrano E; Malara G; Marchesoni A; Olivieri I; Parodi A; Peris K; Piaserico S; Salvarani C; Scarpa R; Girolomoni G
J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):515-528. PubMed ID: 29220551
[TBL] [Abstract][Full Text] [Related]
50. Psoriatic arthritis.
Holdsworth J
Nurs Stand; 2003 Oct 15-21; 18(5):47-52; quiz 54-5. PubMed ID: 14603767
[TBL] [Abstract][Full Text] [Related]
51. Patient characteristics and minimal disease activity in psoriatic arthritis: a transcontinental comparison.
Bakirci S; Ayan G; Gazel U; Tinazzi I; Solmaz D; Kasapoglu E; Kalyoncu U; Aydin SZ
Clin Rheumatol; 2021 Aug; 40(8):3169-3174. PubMed ID: 33598808
[TBL] [Abstract][Full Text] [Related]
52. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
J Rheumatol; 2015 Oct; 42(10):1767-80. PubMed ID: 26178281
[TBL] [Abstract][Full Text] [Related]
53. Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe.
Gottlieb A; Gratacos J; Dikranian A; van Tubergen A; Fallon L; Emir B; Aikman L; Smith T; Chen L
Rheumatol Int; 2019 Jan; 39(1):121-130. PubMed ID: 30426237
[TBL] [Abstract][Full Text] [Related]
54. The approach to precision medicine for the treatment of psoriatic arthritis.
Miyagawa I; Tanaka Y
Immunol Med; 2020 Sep; 43(3):98-102. PubMed ID: 32306849
[TBL] [Abstract][Full Text] [Related]
55. Current and relevant concepts in psoriatic arthritis.
Goldenstein-Schainberg C; Favarato MH; Ranza R
Rev Bras Reumatol; 2012; 52(1):98-106. PubMed ID: 22286649
[TBL] [Abstract][Full Text] [Related]
56. Management of psoriatic arthritis.
Sharma A; Dogra S
Indian J Dermatol Venereol Leprol; 2010; 76(6):645-51. PubMed ID: 21079307
[TBL] [Abstract][Full Text] [Related]
57. Genetic and inflammatory factors associated with psoriatic arthritis: Relevance to diagnosis and management.
Furst DE; Belasco J; Louie JS
Clin Immunol; 2019 May; 202():59-75. PubMed ID: 30738143
[TBL] [Abstract][Full Text] [Related]
58. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study.
Smolen JS; Gladman D; McNeil HP; Mease PJ; Sieper J; Hojnik M; Nurwakagari P; Weinman J
RMD Open; 2019; 5(1):e000585. PubMed ID: 30713716
[TBL] [Abstract][Full Text] [Related]
59. Recommendations for the coordinated management of psoriatic arthritis by rheumatologists and dermatologists: a Delphi study.
Cañete JD; Daudén E; Queiro R; Aguilar MD; Sánchez-Carazo JL; Carrascosa JM; Carretero G; García-Vivar ML; Lázaro P; López-Estebaranz JL; Montilla C; Ramírez J; Rodríguez-Moreno J; Puig L
Actas Dermosifiliogr; 2014 Apr; 105(3):216-32. PubMed ID: 24657018
[TBL] [Abstract][Full Text] [Related]
60. Addressing comorbidities in psoriatic disease.
Patel P; Rosen CF; Chandran V; Ye YJ; Gladman DD
Rheumatol Int; 2018 Feb; 38(2):219-227. PubMed ID: 29185085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
